Your browser doesn't support javascript.
loading
Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib.
Arizumi, Tadaaki; Ueshima, Kazuomi; Chishina, Hirokazu; Kono, Masashi; Takita, Mashiro; Kitai, Satoshi; Inoue, Tatsuo; Yada, Norihisa; Hagiwara, Satoru; Minami, Yasunori; Sakurai, Toshiharu; Nishida, Naoshi; Kudo, Masatoshi.
Affiliation
  • Arizumi T; Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-Sayama, Japan.
Dig Dis ; 32(6): 705-10, 2014.
Article in En | MEDLINE | ID: mdl-25376287

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Niacinamide / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Dig Dis Journal subject: GASTROENTEROLOGIA Year: 2014 Document type: Article Affiliation country: Japón Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Niacinamide / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Dig Dis Journal subject: GASTROENTEROLOGIA Year: 2014 Document type: Article Affiliation country: Japón Country of publication: Suiza